These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34329527)

  • 1. Plasma nontargeted peptidomics discovers potential biomarkers for major depressive disorder.
    Wang Y; Liu X; Liu D; Cheng M; Zhao N; He M; Zhang X
    Proteomics Clin Appl; 2021 Nov; 15(6):e2000058. PubMed ID: 34329527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
    Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
    J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
    Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
    Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
    Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
    Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary peptidomics identifies potential biomarkers for major depressive disorder.
    Wang Y; Chen J; Chen L; Zheng P; Xu HB; Lu J; Zhong J; Lei Y; Zhou C; Ma Q; Li Y; Xie P
    Psychiatry Res; 2014 Jun; 217(1-2):25-33. PubMed ID: 24661976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipidomics reveals potential lipid markers of major depressive disorder.
    Liu X; Li J; Zheng P; Zhao X; Zhou C; Hu C; Hou X; Wang H; Xie P; Xu G
    Anal Bioanal Chem; 2016 Sep; 408(23):6497-507. PubMed ID: 27457104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma amino acid profile in major depressive disorder: Analyses in two independent case-control sample sets.
    Ogawa S; Koga N; Hattori K; Matsuo J; Ota M; Hori H; Sasayama D; Teraishi T; Ishida I; Yoshida F; Yoshida S; Noda T; Higuchi T; Kunugi H
    J Psychiatr Res; 2018 Jan; 96():23-32. PubMed ID: 28950111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Plasma Biomarkers with high specificity for major depressive disorder: A multi-level proteomics study.
    Shi Y; Song R; Wang L; Qi Y; Zhang H; Zhu J; Zhang X; Tang X; Zhan Q; Zhao Y; Swaab DF; Bao AM; Zhang Z
    J Affect Disord; 2020 Dec; 277():620-630. PubMed ID: 32905914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum proteomic analysis of major depressive disorder patients and their remission status: Novel biomarker set of zinc-alpha-2-glycoprotein and keratin type II cytoskeletal 1.
    Choi H; Mun S; Joo EJ; Lee KY; Kang HG; Lee J
    Int J Biol Macromol; 2021 Jul; 183():2001-2008. PubMed ID: 34052271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma biomarker panel for major depressive disorder by quantitative proteomics using ensemble learning algorithm: A preliminary study.
    Zhang L; Liu C; Li Y; Wu Y; Wei Y; Zeng D; He S; Huang J; Li H
    Psychiatry Res; 2023 May; 323():115185. PubMed ID: 37003170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
    Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents.
    Zhou X; Liu L; Lan X; Cohen D; Zhang Y; Ravindran AV; Yuan S; Zheng P; Coghill D; Yang L; Hetrick SE; Jiang X; Benoliel JJ; Cipriani A; Xie P
    Mol Psychiatry; 2019 Oct; 24(10):1478-1488. PubMed ID: 29679072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of argininosuccinate synthase as a candidate urinary biomarker for major depressive disorder.
    Wu D; Peng Y; Zhou J; Yang YT; Rao CL; Bai SJ; Zhou XY; Chen J; Liao L; Liang ZH; Yang DY; Xie P
    Clin Chim Acta; 2015 Dec; 451(Pt B):142-8. PubMed ID: 26394130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of major depressive disorder by combining multimodal information from heart rate dynamics and serum proteomics using machine-learning algorithm.
    Kim EY; Lee MY; Kim SH; Ha K; Kim KP; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():65-71. PubMed ID: 28223106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major depressive disorder is associated with changes in a cluster of serum and urine biomarkers.
    van Buel EM; Meddens MJM; Arnoldussen EA; van den Heuvel ER; Bohlmeijer WC; den Boer JA; Muller Kobold A; Boonman-de Winter LJM; van Rumpt D; Timmers LFJ; Veerman MFA; Kamphuis JS; Gladkevich AV; Schoevers RA; Luiten PGM; Eisel ULM; Bosker FJ; Klein HC
    J Psychosom Res; 2019 Oct; 125():109796. PubMed ID: 31470255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
    Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
    J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential urinary metabolites related with the severity of major depressive disorder.
    Chen JJ; Zhou CJ; Zheng P; Cheng K; Wang HY; Li J; Zeng L; Xie P
    Behav Brain Res; 2017 Aug; 332():280-287. PubMed ID: 28624318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender Differences in Developing Biomarker-Based Major Depressive Disorder Diagnostics.
    Jentsch MC; Burger H; Meddens MBM; Beijers L; van den Heuvel ER; Meddens MJM; Schoevers RA
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization for Peptide Sample Preparation for Urine Peptidomics.
    Sigdel TK; Nicora CD; Qian WJ; Sarwal MM
    Methods Mol Biol; 2018; 1788():63-72. PubMed ID: 29623538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.